NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH
loading...

A Dose of Managed Care: Controlling Drug Spending in Medicaid

David Dranove, Christopher Ody, Amanda Starc

NBER Working Paper No. 23956
Issued in October 2017
NBER Program(s):Health Care Program, Industrial Organization Program

Effectively designed market mechanisms may reduce growth in health care spending. In this paper, we study the impact of privatizing the delivery of Medicaid drug benefits on drug spending. Exploiting granular data that allow us to examine drug utilization, we find that drug spending would fall by 22.4 percent if the drug benefit was fully administered by Medicaid Managed Care Organizations (MCOs), largely through lower point-of-sale prices and greater generic usage. The effects are driven by MCOs’ ability to design drug benefits and steer consumers toward lower cost drugs and pharmacies. MCOs do not appear to skimp on performance, either by reducing overall drug consumption as measured by prescriptions per enrollee or reducing utilization of drugs that offset other medical spending.

download in pdf format
   (1260 K)

email paper

Machine-readable bibliographic record - MARC, RIS, BibTeX

Document Object Identifier (DOI): 10.3386/w23956

Users who downloaded this paper also downloaded* these:
Schaller, Schulkind, and Maghakian Shapiro w23923 The Effects of Perceived Disease Risk and Access Costs on Infant Immunization
Cooper, Kowalski, Powell, and Wu w23748 Politics and Health Care Spending in the United States
Starc and Town w21783 Externalities and Benefit Design in Health Insurance
Finkelstein, Hendren, and Shepard w23668 Subsidizing Health Insurance for Low-Income Adults: Evidence from Massachusetts
Berndt, Conti, and Murphy w23642 The Generic Drug User Fee Amendments: An Economic Perspective
 
Publications
Activities
Meetings
NBER Videos
Themes
Data
People
About

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us